• Citer

High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.

par Willemze, Roel;Suciu, Stefan ;Meloni, Giovanna;Labar, Boris;Marie, Jean Pierre;Halkes, Constantijn CJ;Muus, Petra;Mistrik, Martin;Amadori, Sergio;Specchia, Giorgina;Fabbiano, Francesco;Nobile, Francesco;Sborgia, Marco;Camera, Andrea;Selleslag, Dominik;Lefrère, Francois;Magro, Domenico;Sica, Simona;Cantore, Nicola;Beksac, Meral Sinan;Berneman, Zwi;Thomas, Xavier;Melillo, Lorella;Guimaraes, Jose E;Leoni, Pietro;Luppi, Mario;Mitra, Maria E;Bron, Dominique ;Fillet, Georges;Marijt, Erik EW;Venditti, Adriano;Hagemeijer, Anne;Mancini, M.;Jansen, Joop;Cilloni, Daniela;Meert, L;Fazi, Paola;Vignetti, Marco;Trisolini, Silvia SM;Mandelli, Franco;De Witte, Theo
Référence Journal of clinical oncology, 32, 3, page (219-228)
Publication Publié, 2014-01

Article révisé par les pairs

• Détails
• Contenu

Titre:	High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
Auteur:	Willemze, Roel; Suciu, Stefan; Meloni, Giovanna; Labar, Boris; Marie, Jean Pierre; Halkes, Constantijn CJ; Muus, Petra; Mistrik, Martin; Amadori, Sergio; Specchia, Giorgina; Fabbiano, Francesco; Nobile, Francesco; Sborgia, Marco; Camera, Andrea; Selleslag, Dominik; Lefrère, Francois; Magro, Domenico; Sica, Simona; Cantore, Nicola; Beksac, Meral Sinan; Berneman, Zwi; Thomas, Xavier; Melillo, Lorella; Guimaraes, Jose E; Leoni, Pietro; Luppi, Mario; Mitra, Maria E; Bron, Dominique; Fillet, Georges; Marijt, Erik EW; Venditti, Adriano; Hagemeijer, Anne; Mancini, M.; Jansen, Joop; Cilloni, Daniela; Meert, L; Fazi, Paola; Vignetti, Marco; Trisolini, Silvia SM; Mandelli, Franco; De Witte, Theo
Informations sur la publication:	Journal of clinical oncology, 32, 3, page (219-228)
Statut de publication:	Publié, 2014-01
Sujet CREF:	Hématologie
MeSH keywords:	Adolescent
	Adult
	Antimetabolites, Antineoplastic -- administration & dosage
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Consolidation Chemotherapy
	Cytarabine -- administration & dosage
	Daunorubicin -- administration & dosage
	Drug Administration Schedule
	Etoposide -- administration & dosage
	Europe
	Female
	Humans
	Induction Chemotherapy -- methods
	Infusions, Intravenous
	Leukemia, Myeloid, Acute -- diagnosis -- drug therapy -- genetics
	Male
	Middle Aged
	Mutation
	Risk Assessment
	Risk Factors
	Treatment Outcome
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2013.51.8571
	info:pii/JCO.2013.51.8571
	info:scp/84897018280
	info:pmid/24297940